This study is currently not recruiting participants.

Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab Versus Conventional Concurrent Chemoradiation and Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma

Investigating the Effectiveness of Adding an Investigational Medication to Standard Chemoradiation Treatment

Not Recruiting
18 years - 100 years
All
Phase N/A

Brief description of study.

The purpose of this study is to find out whether the addition of bevacizumab to the standard chemoradiation treatment will further improve the outcome.

Detailed description of study

The purpose of this study is to find out whether the addition of bevacizumab to the standard chemoradiation treatment will further improve the outcome.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Brain Cancer (Glioblastoma)
  • Age: 18 years - 100 years
  • Gender: All

The purpose of this study is to investigate whether adding an investigational medication to the standard chemoradiation treatment can improve outcomes for patients. Chemoradiation is a combination of chemotherapy and radiation therapy used to treat cancer. This study aims to explore if the investigational medication can enhance the effectiveness of this treatment.

Participants in this study will receive either the standard chemoradiation treatment alone or with the addition of the investigational medication. The study will involve regular monitoring and assessments to evaluate the treatment's impact on the participants' health.

  • Who can participate: Eligibility criteria may include adult patients with a specific type of cancer suitable for chemoradiation treatment. Further details will be provided by the study coordinators.
  • Study details: Participants will be randomly assigned to receive either the standard treatment or the treatment with the investigational medication. A placebo, which is an inactive substance that looks like the investigational medication but does not contain any medicine, may be used.
Updated on 19 Feb 2024. Study ID: 1105005566 (09-035)

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team